Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer. (Q35635056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mark G Kris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Craig P Nolan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Antonio Omuro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Yelena Y Janjigian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christopher G Azzoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Maria C Pietanza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Andrei I Holodny

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Andrew B Lassman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

1 reference

4 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

443-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-010-0200-2

1 February 2020

exact match

0 references

cites work

Bevacizumab safety in patients with central nervous system metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

What is the risk of intracranial bleeding during anti-VEGF therapy?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Safety of anticoagulation use and bevacizumab in patients with glioma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246379

Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20440540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20440540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-010-0200-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440540%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference